tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ARVN Stock Latest News

Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
Press ReleasesArvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress
6h ago
ARVN
Arvinas price target lowered to $70 from $80 at Oppenheimer
PremiumThe Fly
Arvinas price target lowered to $70 from $80 at Oppenheimer
2d ago
ARVN
Arvinas price target lowered to $65 from $77 at Leerink
PremiumThe Fly
Arvinas price target lowered to $65 from $77 at Leerink
2d ago
ARVN
Arvinas reports Q1 EPS (97c), consensus ($1.41)
PremiumThe Fly
Arvinas reports Q1 EPS (97c), consensus ($1.41)
3d ago
ARVN
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress Releases
Arvinas Reports First Quarter 2024 Financial Results and Provides Corporate Update
3d ago
ARVN
Biotech Sector: M&A Fuels Renewed Excitement
PremiumMarket NewsBiotech Sector: M&A Fuels Renewed Excitement
10d ago
NVS
XBI
Arvinas price target lowered to $38 from $55 at Citi
PremiumThe Fly
Arvinas price target lowered to $38 from $55 at Citi
11d ago
ARVN
Arvinas appoints Randy Teel Chief Business Officer
PremiumThe Fly
Arvinas appoints Randy Teel Chief Business Officer
15d ago
ARVN
Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer
PremiumPress Releases
Arvinas Appoints Randy Teel, Ph.D., as Chief Business Officer
15d ago
ARVN
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
24d ago
PFE
ARVN
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
24d ago
PFE
ARVN
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
PremiumThe Fly
Cantor Fitzgerald biotech/biopharma analysts analyst/industry conference call
24d ago
PFE
ARVN
Arvinas price target lowered to $87 from $90 at H.C. Wainwright
PremiumThe FlyArvinas price target lowered to $87 from $90 at H.C. Wainwright
25d ago
ARVN
Arvinas Partners with Novartis on Prostate Cancer Therapy
PremiumCompany Announcements
Arvinas Partners with Novartis on Prostate Cancer Therapy
29d ago
8K
ARVN
Arvinas enters exclusive strategic license agreement with Novartis for ARV-766
PremiumThe Fly
Arvinas enters exclusive strategic license agreement with Novartis for ARV-766
29d ago
NVS
ARVN
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
PremiumPress Releases
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
29d ago
ARVN
Arvinas Appoints New Chief Medical Officer for Clinical Programs
PremiumCompany Announcements
Arvinas Appoints New Chief Medical Officer for Clinical Programs
2M ago
8K
ARVN
Arvinas names Noah Berkowitz as Chief Medical Officer
PremiumThe Fly
Arvinas names Noah Berkowitz as Chief Medical Officer
2M ago
ARVN
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
PremiumPress Releases
Arvinas Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer
2M ago
ARVN
Arvinas to Participate in Upcoming Investor Conferences
PremiumPress ReleasesArvinas to Participate in Upcoming Investor Conferences
2M ago
ARVN
Arvinas price target raised to $60 from $26 at Barclays
PremiumThe Fly
Arvinas price target raised to $60 from $26 at Barclays
2M ago
ARVN
Arvinas price target raised to $59 from $33 at Wedbush
PremiumThe Fly
Arvinas price target raised to $59 from $33 at Wedbush
2M ago
ARVN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >